Novartis AG

SIX:NOVN.SW

98.04 (CHF) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) CHF.

20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998
Operating Activities:
Net Income 8,5726,95524,0188,0717,14712,6147,7036,6987,02810,7279,2929,6189,2459,9698,4548,1636,5407,0196,1415,7675,0165,2244,2394,3954,1880
Depreciation & Amortization 8,2777,1816,1136,4645,8266,8926,0766,0435,5754,7514,9904,9545,7883,4192,3012,6702,8581,9871,7171,3391,2836905859189491,008.721
Deferred Income Tax 5511,4162,1191,8071,7931,2211,2961,1191,1061,5451,4431,6251,5281,7331,4681,3369471,2821,1241,1261,00800000
Stock Based Compensation 8657917007387587596836717737447307467906556425675705224150000000
Change In Working Capital -369-1,003241-291199499244-77-863-625-739-140-1131,762688-630-535166872132457-126124-202-618-670.058
Accounts Receivables -1,504-589-389137-980-569-204-229-513-367-411369-73226-934-431-2040-490-13029700000
Inventory -546-83081-543-382-533-247-235-482-506-653-70145965237-571-747-11717523-78-490-461402950
Accounts Payables 479-48-21-32455330958-5873781425025151954905122463230-5423923800000
Other Working Capital 1,2024645704391,0081,292637974-246106-177-323379281873126932831,24100364170-342-9130
Other Non Cash Items -3,438-1,136-18,156-3,139-2,098-7,713-3,381-2,979-1,722-3,245-2,542-2,609-2,929-3,471-1,362-2,337-1,170-2,266-2,189-1,639-1,11242-517-470-1843,938.953
Operating Cash Flow 14,45814,23615,07113,65013,62514,27212,62111,47511,89713,89713,17414,19414,30914,06712,1919,7699,2108,7108,0806,7256,6525,8304,4314,6414,3354,277.616
Investing Activities:
Investments In Property Plant And Equipment -2,753-2,671-2,971-2,585-2,257-3,355-2,746-2,879-3,851-3,703-3,775-3,305-2,387-2,232-2,733-2,316-3,133-2,322-1,548-1,450-1,543-1,186-815-825-862-1,129.36
Acquisitions Net -3,569-90320,102-9,964-3,766-1,068-755-765-16,507-331-42-1,741-581-26,666-1,006-11,526-62-4,523-8,866-1,031-402-605-102-836107170.785
Purchases Of Investments -747-34,816-16,594-2,130-530-2,702-1,048-777-859-408-443-1,123-1,937-40,708-14,341-4,156-7,543-5,561-4,823-8,062-10,923-7,383166212-1,1040
Sales Maturities Of Investments 11,59639,4902,7401,2153,7136398798694282,5175647373,40953,2693,7627,4044,2535,6317,4327,01110,5117,8601,5532,9511800
Other Investing Activites 1,069368931282614895-499-9068,5211,727-367-85096827-74717-343-320-37132845-1,868-3,457-1,421-388.721
Investing Cash Flow 5,5961,4684,208-13,182-2,226-5,591-3,119-3,441-10,784881-3,352-5,675-792-15,756-14,219-10,367-6,244-6,575-7,482-3,219-1,298-3,182-2,821-131-1,897-949.855
Financing Activities:
Debt Repayment -2,481-2,870-2,440-2,315-3,468-366-188-1,696-3,086-2,599-2,022-704-28-5-22-68-59-182-884-15-3,4890-985000
Common Stock Issued 3,9850010,0851,9695,2374,4303,9655,0475,9176894141637307242,8751,8492546760002,448001.453
Common Stock Repurchased -8,719-10,652-3,057-2,842-5,533-2,036-5,490-1,109-4,490-4,515-1,237-91-3,628-311-461-3,348-6,448-2,726-231-1,874-273-3,676-2,322-710-1,207-15.262
Dividends Paid -7,255-7,506-7,368-6,987-6,645-6,966-6,495-6,475-6,643-6,810-6,100-6,030-5,368-4,486-3,941-3,345-2,598-2,049-2,107-1,968-1,724-1,639-1,324-1,259-1,2170
Other Financing Activities 192466-3,399-14950-1134,4403,9665,0435,777590-264-6,1638,1886,5091,313-2,062-2,9932,889673-278589984-931-293-4,537.791
Financing Cash Flow -14,278-20,562-16,264-2,208-13,627-4,244-7,733-5,314-9,176-8,147-8,769-6,675-15,0244,1162,809-2,573-9,318-4,970-266-3,124-5,764-4,726-214-2,900-2,717-4,551.599
Other Information:
Effect Of Forex Changes On Cash 100-32-26628669-2684-387-286-29582-1-103-275-4629825-9455258-7119-7346-22.529
Net Change In Cash 5,876-4,8902,749-1,454-2,1594,4111,8532,333-8,3496,3361,1351,843-1,6102,425856-3,3221,545-2,506238437-152-2,1491,4141,537-233-1,246.366
Cash At End Of Period 13,3937,51712,4079,65811,11213,2718,8607,0074,67413,0236,6875,5523,7095,3192,8942,0385,3603,8156,3216,0835,6465,8136,7275,3683,9505,060.32